FDA Calendar

Sunday, June 12, 2011

My Watchlist for week of 6/13

ACUR - PDUFA 6/17 Acurox
FCSC - PDUFA 6/22 azficel-T, proposed brand name laViv®,”
LCI - PDUFA 6/23 Morphine Sulfate Oral Solution.
ALXA - new drug application (NDA) on AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia or bipolar disorder by the end of July 2011.

Holding FCSC & ANX
Posted by Biotechtrader34 at 5:02 PM
Labels: , , ,

1 comment:

  1. Gary J. PalysJuly 3, 2011 at 8:51 AM

    Where do you think a good buy in point would be for DVAX at this stage of the game?

    ReplyDelete

Subscribe to: Post Comments (Atom)